Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | FAD binding domain containing protein | 0.0418 | 0.5883 | 0.5843 |
Schistosoma mansoni | NADPH flavin oxidoreductase | 0.0341 | 0.4659 | 0.4568 |
Loa Loa (eye worm) | glycosyl hydrolase family 2 | 0.0059 | 0.0168 | 0.0072 |
Schistosoma mansoni | alpha-l-fucosidase | 0.02 | 0.2422 | 0.2292 |
Plasmodium falciparum | S-adenosyl-L-methionine-dependent tRNA 4-demethylwyosine synthase, putative | 0.0259 | 0.3354 | 0.3033 |
Trichomonas vaginalis | glycoside hydrolase, putative | 0.0113 | 0.1028 | 0.042 |
Echinococcus granulosus | fucosidase alpha L 1 tissue | 0.0331 | 0.4505 | 0.4239 |
Leishmania major | p450 reductase, putative | 0.0676 | 1 | 1 |
Schistosoma mansoni | 5-methyl tetrahydrofolate-homocysteine methyltransferase reductase | 0.0418 | 0.5883 | 0.5813 |
Echinococcus granulosus | lysosomal alpha glucosidase | 0.0083 | 0.0556 | 0.01 |
Echinococcus multilocularis | lysosomal alpha glucosidase | 0.0083 | 0.0556 | 0.01 |
Brugia malayi | Alpha-L-fucosidase family protein | 0.02 | 0.2422 | 0.2348 |
Trichomonas vaginalis | NADPH cytochrome P450, putative | 0.0259 | 0.3354 | 0.2904 |
Entamoeba histolytica | type A flavoprotein, putative | 0.0259 | 0.3354 | 1 |
Echinococcus multilocularis | lysosomal alpha glucosidase | 0.0083 | 0.0556 | 0.01 |
Echinococcus granulosus | NADPH dependent diflavin oxidoreductase 1 | 0.0676 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0113 | 0.1028 | 0.042 |
Toxoplasma gondii | MAPEG family protein | 0.0109 | 0.0978 | 0.1257 |
Schistosoma mansoni | alpha-glucosidase | 0.0071 | 0.0372 | 0.0208 |
Schistosoma mansoni | lipoxygenase | 0.0081 | 0.052 | 0.0358 |
Toxoplasma gondii | flavodoxin domain-containing protein | 0.0336 | 0.4578 | 1 |
Trypanosoma brucei | S-adenosyl-L-methionine-dependent tRNA 4-demethylwyosine synthase, putative | 0.0259 | 0.3354 | 0.3033 |
Echinococcus multilocularis | NADPH cytochrome P450 reductase | 0.0676 | 1 | 1 |
Trypanosoma cruzi | cytochrome P450 reductase, putative | 0.0676 | 1 | 1 |
Trichomonas vaginalis | NADPH cytochrome P450, putative | 0.0259 | 0.3354 | 0.2904 |
Trypanosoma cruzi | p450 reductase, putative | 0.0676 | 1 | 1 |
Brugia malayi | Glycosyl hydrolases family 2, sugar binding domain containing protein | 0.0059 | 0.0168 | 0.0072 |
Trypanosoma cruzi | Flavodoxin/Radical SAM superfamily/Wyosine base formation, putative | 0.0259 | 0.3354 | 0.3033 |
Schistosoma mansoni | cytochrome B5 | 0.0077 | 0.0461 | 0.0297 |
Plasmodium falciparum | NADPH--cytochrome P450 reductase, putative | 0.0259 | 0.3354 | 0.3033 |
Plasmodium falciparum | nitric oxide synthase, putative | 0.0676 | 1 | 1 |
Mycobacterium ulcerans | alpha-L-fucosidase | 0.0331 | 0.4505 | 0.4239 |
Trichomonas vaginalis | beta-galactosidase, putative | 0.0113 | 0.1028 | 0.042 |
Echinococcus multilocularis | NADPH dependent diflavin oxidoreductase 1 | 0.0676 | 1 | 1 |
Schistosoma mansoni | lipoxygenase | 0.0115 | 0.1072 | 0.0919 |
Schistosoma mansoni | NADH-cytochrome B5 reductase | 0.0077 | 0.0461 | 0.0297 |
Echinococcus multilocularis | microsomal glutathione S transferase 3 | 0.0109 | 0.0978 | 0.0542 |
Leishmania major | NADPH-cytochrome p450 reductase-like protein | 0.0676 | 1 | 1 |
Mycobacterium tuberculosis | Probable monooxygenase | 0.0077 | 0.0461 | 0.5 |
Loa Loa (eye worm) | FAD binding domain-containing protein | 0.0418 | 0.5883 | 0.5843 |
Trypanosoma cruzi | NADPH--cytochrome P450 reductase, putative | 0.0259 | 0.3354 | 0.3033 |
Loa Loa (eye worm) | diaphorase | 0.0077 | 0.0461 | 0.0368 |
Plasmodium vivax | flavodoxin domain containing protein | 0.0599 | 0.8776 | 0.8717 |
Mycobacterium tuberculosis | Probable oxidoreductase | 0.0077 | 0.0461 | 0.5 |
Trichomonas vaginalis | sulfite reductase, putative | 0.0676 | 1 | 1 |
Echinococcus granulosus | microsomal glutathione S transferase 3 | 0.0109 | 0.0978 | 0.0542 |
Brugia malayi | flavodoxin family protein | 0.0259 | 0.3354 | 0.3289 |
Trypanosoma brucei | NADPH-dependent diflavin oxidoreductase 1 | 0.0676 | 1 | 1 |
Entamoeba histolytica | type A flavoprotein, putative | 0.0259 | 0.3354 | 1 |
Loa Loa (eye worm) | cytochrome b5 reductase 4 | 0.0077 | 0.0461 | 0.0368 |
Echinococcus multilocularis | fucosidase, alpha L 1, tissue | 0.0331 | 0.4505 | 0.4239 |
Loa Loa (eye worm) | FAD binding domain-containing protein | 0.0676 | 1 | 1 |
Entamoeba histolytica | type A flavoprotein, putative | 0.0259 | 0.3354 | 1 |
Loa Loa (eye worm) | flavodoxin family protein | 0.0259 | 0.3354 | 0.3289 |
Plasmodium vivax | hypothetical protein, conserved | 0.0259 | 0.3354 | 0.3033 |
Giardia lamblia | Hypothetical protein | 0.0599 | 0.8776 | 1 |
Plasmodium vivax | NADPH-cytochrome p450 reductase, putative | 0.0676 | 1 | 1 |
Giardia lamblia | Nitric oxide synthase, inducible | 0.0599 | 0.8776 | 1 |
Mycobacterium ulcerans | formate dehydrogenase H FdhF | 0.0676 | 1 | 1 |
Trypanosoma brucei | NADPH-cytochrome p450 reductase, putative | 0.0676 | 1 | 1 |
Schistosoma mansoni | alpha-glucosidase | 0.0071 | 0.0372 | 0.0208 |
Echinococcus granulosus | arachidonate 5 lipoxygenase | 0.0115 | 0.1072 | 0.0641 |
Loa Loa (eye worm) | alpha-L-fucosidase | 0.02 | 0.2422 | 0.2348 |
Leishmania major | cytochrome P450 reductase, putative | 0.0599 | 0.8776 | 0.8717 |
Brugia malayi | diaphorase | 0.0077 | 0.0461 | 0.0368 |
Schistosoma mansoni | cytochrome P450 reductase | 0.0676 | 1 | 1 |
Brugia malayi | manba-prov protein | 0.0093 | 0.0718 | 0.0627 |
Entamoeba histolytica | type A flavoprotein, putative | 0.0259 | 0.3354 | 1 |
Schistosoma mansoni | memapsin-2 (A01 family) | 0.0308 | 0.4135 | 0.4035 |
Chlamydia trachomatis | sulfite reductase | 0.0418 | 0.5883 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0259 | 0.3354 | 0.3033 |
Mycobacterium tuberculosis | Possible electron transfer protein FdxB | 0.0077 | 0.0461 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0676 | 1 | 1 |
Brugia malayi | Glycosyl hydrolases family 31 protein | 0.0083 | 0.0556 | 0.0464 |
Trypanosoma brucei | NADPH--cytochrome P450 reductase, putative | 0.0676 | 1 | 1 |
Echinococcus granulosus | methionine synthase reductase | 0.0418 | 0.5883 | 0.5684 |
Loa Loa (eye worm) | glycosyl hydrolase family 31 protein | 0.0083 | 0.0556 | 0.0464 |
Schistosoma mansoni | diflavin oxidoreductase | 0.0336 | 0.4578 | 0.4485 |
Trypanosoma cruzi | cytochrome P450 reductase, putative | 0.0676 | 1 | 1 |
Trichomonas vaginalis | NADPH fad oxidoreductase, putative | 0.0599 | 0.8776 | 0.8694 |
Echinococcus multilocularis | arachidonate 5 lipoxygenase | 0.0115 | 0.1072 | 0.0641 |
Entamoeba histolytica | type A flavoprotein, putative | 0.0259 | 0.3354 | 1 |
Trichomonas vaginalis | NADPH cytochrome P450, putative | 0.0259 | 0.3354 | 0.2904 |
Trypanosoma brucei | NADPH--cytochrome P450 reductase, putative | 0.0676 | 1 | 1 |
Trichomonas vaginalis | NADPH cytochrome P450, putative | 0.0259 | 0.3354 | 0.2904 |
Mycobacterium tuberculosis | Hypothetical oxidoreductase | 0.0077 | 0.0461 | 0.5 |
Onchocerca volvulus | 0.0077 | 0.0461 | 1 | |
Schistosoma mansoni | nuclear hormone receptor superfamily protein-related | 0.0345 | 0.4735 | 0.4645 |
Treponema pallidum | flavodoxin | 0.0259 | 0.3354 | 1 |
Brugia malayi | Cytochrome b5-like Heme/Steroid binding domain containing protein | 0.0077 | 0.0461 | 0.0368 |
Mycobacterium tuberculosis | Possible oxygenase | 0.0077 | 0.0461 | 0.5 |
Toxoplasma gondii | flavodoxin domain-containing protein | 0.0336 | 0.4578 | 1 |
Trypanosoma cruzi | Flavodoxin/Radical SAM superfamily/Wyosine base formation, putative | 0.0259 | 0.3354 | 0.3033 |
Trypanosoma cruzi | NADPH-dependent FMN/FAD containing oxidoreductase, putative | 0.0676 | 1 | 1 |
Echinococcus multilocularis | methionine synthase reductase | 0.0418 | 0.5883 | 0.5684 |
Schistosoma mansoni | membrane associated proteins in eicosanoid and glutathione metabolism family member | 0.0477 | 0.6834 | 0.678 |
Schistosoma mansoni | microsomal glutathione s-transferase | 0.0109 | 0.0978 | 0.0824 |
Brugia malayi | FAD binding domain containing protein | 0.0676 | 1 | 1 |
Echinococcus granulosus | NADPH cytochrome P450 reductase | 0.0676 | 1 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.